Share-based Payment Arrangement, Expense in USD of CITIUS ONCOLOGY, INC. from Q4 2023 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
CITIUS ONCOLOGY, INC. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q4 2023 to Q2 2025.
  • CITIUS ONCOLOGY, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2025 was $2.13M, a 8.6% increase year-over-year.
  • CITIUS ONCOLOGY, INC. Share-based Payment Arrangement, Expense for the twelve months ending 30 Jun 2025 was $7.69M.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)

CITIUS ONCOLOGY, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $7.69M $2.13M +$168K +8.6% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $7.52M $2.09M +$132K +6.72% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $7.39M $1.81M -$109K -5.66% 01 Oct 2024 31 Dec 2024 10-Q 14 Feb 2025
Q3 2024 $7.5M $1.67M 01 Jul 2024 30 Sep 2024 10-K 27 Dec 2024
Q2 2024 $1.96M 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 $1.96M 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 $1.92M 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2025

CITIUS ONCOLOGY, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $7.5M 01 Oct 2023 30 Sep 2024 10-K 27 Dec 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.